Jeffrey Perez - Precigen President

I5X Stock  EUR 0.85  0.02  2.41%   

President

Mr. Jeffrey T. Perez is Senior Vice President Intellectual Property Affairs of Intrexon Corporationrationration. Before joining Intrexon, Mr. Perez was Managing Director and Associate General Counsel and Intellectual Property at Third Security, LLC, where he evaluated potential investments of Third Securitys managed investment funds. Additionally, Mr. Perez worked with Third Security portfolio companies in evaluating and developing their intellectual property strategies and general corporate activities. Prior to joining Third Security, Mr. Perez practiced intellectual property law with the law firm of Hunton Williams LLP in Washington D.C. Mr. Perezs previous work involved client consultation, litigation, agreement work, opinion drafting and patent procurement since 2014.
Age 51
Tenure 10 years
Phone301 556 9900
Webhttps://www.precigen.com
Perez received a B.S. from Cornell University and his J.D. from George Mason University School of Law.

Precigen Management Efficiency

The company has return on total asset (ROA) of (0.1219) % which means that it has lost $0.1219 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5132) %, meaning that it generated substantial loss on money invested by shareholders. Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities.
Precigen has accumulated 182.75 M in total debt with debt to equity ratio (D/E) of 1.05, which is about average as compared to similar companies. Precigen has a current ratio of 5.6, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Precigen until it has trouble settling it off, either with new capital or with free cash flow. So, Precigen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Precigen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Precigen to invest in growth at high rates of return. When we think about Precigen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

PRESIDENT Age

Adam PollitzerNMI Holdings
43
Andrew PeytonSuperior Plus Corp
55
William LeatherberryNMI Holdings
52
John SwensonNMI Holdings
N/A
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. PRECIGEN INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 423 people. Precigen (I5X) is traded on Frankfurt Exchange in Germany and employs 456 people.

Management Performance

Precigen Leadership Team

Elected by the shareholders, the Precigen's board of directors comprises two types of representatives: Precigen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Precigen. The board's role is to monitor Precigen's management team and ensure that shareholders' interests are well served. Precigen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Precigen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steven Frank, Independent Director
Jeffrey Kindler, Independent Director
Rob Russell, VP HR
Randal Kirk, Chairman of the Board, Chief Executive Officer
Rick Sterling, Chief Financial Officer
Cesar Alvarez, Independent Director
Donald Lehr, Chief Legal Officer
Vinita Gupta, Independent Director
Rutul Shah, Chief Officer
Jeffrey Perez, Senior Vice President — Intellectual Property Affairs
Randal JD, Ex Chairman
Helen MPH, CEO Pres
Steven Harasym, VP Relations
Fred Hassan, Independent Director
James Turley, Independent Director
Helen Sabzevari, President, Chief Executive Officer, President - Precigen, Inc.
Harry Thomasian, Chief Officer
Marie Rossi, VP Communications
Dean Mitchell, Independent Director
Thomas Reed, Founder, Chief Science Officer
Robert Shapiro, Lead Independent Director

Precigen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Precigen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Precigen Stock

When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Precigen Stock please use our How to Invest in Precigen guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.